| LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 |
901 NEW YORK AVENUE, NW, #510E
| Address2 |
|
| City |
WASHINGTON
| State |
DC
| Zip Code |
20001
| Country |
USA
|
3. Principal place of business (if different than line 2)
| City |
Irving
| State |
TX
| Zip Code |
75039
| Country |
USA
|
| 5. Senate ID# 40021-00012
|
||||||||
| 6. House ID# 313240000
|
||||||||
| TYPE OF REPORT | 8. Year |
2011
| Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
| 11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
| Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature |
Digitally Signed By: Michael J. Regier, Senior Vice President of Legal and Corporate Affairs and General Counsel
| Date |
01/13/2012
|
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Physician Payments - Supported efforts to correct sustainable growth rate formula to avoid major cuts in Medicare payments to physicians, but opposed using cuts to hospital payments to help offset the cost of such legislation.
H.R. 3630 - opposed provisions in the legislation that would make cuts in hospital payments.
Joint Select Committee on Deficit Reduction - Monitored activity of the Select Committee on Deficit Reduction and advocated against cuts to Medicare and Medicaid payments for hospitals.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Shortage of Prescription Drugs - Supported legislation (S. 296, H.R. 2245) that would require greater reporting of possible drug shortages. Monitored congressional activity in search of solutions to ongoing drug shortage problem.
Group Purchasing Organizations - Education and outreach efforts regarding the value that GPOs bring to hospitals. Monitored and engaged on congressional investigatory efforts regarding group purchasing and health care supply chain.
Independent Payment Advisory Board - (S.668, H.R. 452) - Supported legislation that would repeal the Independent Payment Advisory Board.
Unique Device Identification - Urged federal regulators to release regulations establishing a national unique identification system for medical devices as required under the Food and Drug Administration Amendments Act of 2007.
340 B (of the Public Health Service Act) Drug Pricing Program - monitored legislative proposals that would expand the 340 B prescription drug pricing program to inpatient hospitals.
Confidentiality of Medical Information - tracked and engaged on regulatory efforts stemming from the HITECH Act that would require accounting for disclosures of medical information and enhanced reporting for HIPAA covered entities.
Outreach and education efforts with policymakers on VHA initiatives doing to improve hospital clinical performance.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Not-for-profit hospital tax exemption - Monitored regulatory proposals for not-for-profit, tax-exempt hospitals stemming from the Affordable Care Act. Advocated against the inclusion of redundant and overly proscriptive reporting requirements in the IRS Form 990 Schedule H. Tracked developments on hospital community health needs assessment requirements.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS), Treasury - Dept of, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
| State |
| Zip Code |
| Country |
|
21. Client new principal place of business (if different than line 20)
| City |
| State |
| Zip Code |
| Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
| 3 |
|
||||||
| 2 |
| 4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address | Principal place of business (city and state or country) | Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
|
||||||||||||||
|
|
| % | ||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |